Polycystic Ovarian Syndrome Therapeutics Market Report – Forecast (2023-2028)

The Polycystic Ovarian Syndrome Therapeutics Market size is estimated to reach $6.3 billion by 2028, growing at a CAGR of 4.9% during the forecast period 2023-2028. Polycystic ovary syndrome (PCOS) is a complicated condition characterized by high androgen levels, menstrual inconsistencies and/or small cysts on one or both ovaries. PCOS is connected with an excess of cardio-metabolic results. A number of women enduring polycystic ovary syndrome may be recommended antidepressants to rectify the impacts of depression. Anti-obesity agents that have been investigated in PCOS involve orlistat, sibutramine and rimonabant.